Accelerating time to market for new drugs

This white paper by BroadVision Inc. explores business-to-business solutions that can help pharmaceutical companies ensure effective collaboration with partners. Pharma companies are increasingly outsourcing clinical trials and molecule synthesis to independent service providers to help follow up on drug candidate leads. This paper describes the possibilities of collaboration such as improving the quality and reliability of research results and expediting the new drug approval process. It also discusses safeguarding intellectual property and quality research.

Published:	2002
Format:	PDF
Length:	10 pages
Type:	White paper
Language:	English

• Email This Page
• Print This Page